This inventor holds 1 USPTO granted patent. Top assignee: Vufb A.s. Active years: 1997.
Company Filing History:
Years Active: 1997
Title: Jiri Hrbata: Innovator in Antitumor Drug Development
Introduction
Jiri Hrbata is a notable inventor based in Olsany, Czech Republic. He has made significant contributions to the field of medicinal chemistry, particularly in the development of antitumor compounds. His innovative work has led to the creation of a patent that showcases his expertise in this vital area of research.
Latest Patents
Hrbata holds a patent for "6-[X-(2-hydroxyethyl)aminoalkyl]-5,11-dioxo-5,6-dihydro-11H-indeno[-1,2-c]isoquinoline derivatives." This patent describes a series of compounds represented by a general formula, where X indicates the number of carbon atoms in the aminoalkyl group. These compounds are particularly effective in treating malignant neoplasias in mammals. The preparation of these antitumor compounds involves specific chemical reactions, including the use of N-(hydroxyethyl)alkylen diamine in aprotic solvents like dimethylformamide.
Career Highlights
Hrbata is associated with Vufb A.s., where he continues to contribute to the field of drug development. His work focuses on creating new compounds that can be utilized in the treatment of cancer. His innovative approach and dedication to research have positioned him as a key figure in medicinal chemistry.
Collaborations
Hrbata has collaborated with notable individuals in his field, including Jiri Michalsky and Jiri Krepelka. These collaborations have further enhanced his research and development efforts, leading to advancements in antitumor therapies.
Conclusion
Jiri Hrbata's contributions to the field of medicinal chemistry, particularly in the development of antitumor drugs, highlight his innovative spirit and dedication to improving healthcare. His patent and ongoing research efforts continue to pave the way for new treatments in the fight against cancer.